US, Jan. 19 -- In the fight against COVID-19 to get the UK population vaccinated, leading gene and cell therapy organisation - Oxford Biomedica - has announced the formal opening of its newest 84,000 square feet manufacturing facility, known as Oxbox, in Oxford.
The latest news follows the organisation's announcement that AstraZeneca's COVID-19 vaccine was authorised for emergency supply in the UK.
"This emergency use authorisation marks a landmark day for the UK in the fight against COVID-19 [...] At Oxford Biomedica we are proud to be part of this effort, led by AstraZeneca and Oxford University, to bring a safe and efficacious vaccine to market in less than a year," stated John Dawson, Chief Executive Officer of Oxford Biomedica on th...